ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

NCT06570031 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Hormone Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer

Interventions

DRUG: ONO-4578
DRUG: letrozole
DRUG: Palbociclib
DRUG: abemaciclib

Sponsor

Ono Pharmaceutical Co., Ltd.